CHRONIC SUPPURATIVE OTITIS MEDIA: PATHOGENESIS, DIAGNOSIS, CONTEMPORARY MANAGEMENT AND FUTURE DIRECTIONS. A NARRATIVE REVIEW

Authors

  • Homitov Olimjon Dilshodovich Asia International University, Bukhara, Uzbekistan

Keywords:

chronic suppurative otitis media; tympanic membrane perforation; biofilm; Pseudomonas aeruginosa; tympanoplasty; cholesteatoma; conductive hearing loss; topical quinolones

Abstract

Chronic suppurative otitis media (CSOM) is a persistent inflammatory disease of the middle ear and mastoid cleft, characterised by tympanic membrane perforation and recurrent or continuous otorrhoea lasting more than two to six weeks. It remains a major cause of preventable conductive hearing loss, particularly in low- and middle-income countries and in socio-economically disadvantaged communities, and it carries a risk of intratemporal and intracranial complications. Recent advances in microbiology, imaging and surgical technique, together with Cochrane-level evidence on topical therapy, have changed many aspects of care. This narrative review synthesises current knowledge on the epidemiology, risk factors and pathogenesis of CSOM, including the central role of biofilms, polymicrobial infection and impaired mucosal immunity; summarises the clinical and instrumental diagnostic work-up; and appraises contemporary medical and surgical management. Evidence supports meticulous aural toilet combined with topical quinolone antibiotics as first-line therapy, while systemic antibiotics are reserved for selected situations and surgery (tympanoplasty with or without mastoidectomy) is indicated for persistent perforation, cholesteatoma and complications. Emerging directions include endoscopic ear surgery, anti-biofilm agents, bacteriophage therapy, rapid molecular diagnostics, artificial-intelligence-assisted otoscopy and tele-otology. Gaps remain in standardised definitions, paediatric trials, antimicrobial-resistance surveillance and implementation research in resource-limited settings.

References

1.Farxodivich TF. Cholestasis is a risk factor for the development of gallstone disease. Nauchnyi Fokus. 2024;2(21):317–321.

2.Bhutta MF, Thornton RB, Kirkham LA, Kerschner JE, Cheeseman MT. Understanding the aetiology and resolution of chronic otitis media from animal and human studies. Dis Model Mech. 2017;10(11):1289-1300.

3.Poorey VK, Iyer A. Study of bacterial flora in CSOM and its clinical significance. Indian J Otolaryngol Head Neck Surg. 2002;54(2):91-95.

4.Yeo SG, Park DC, Hong SM, Cha CI, Kim MG. Bacteriology of chronic suppurative otitis media: a multicenter study. Acta Otolaryngol. 2007;127(10):1062-1067.

5.Prakash R, Juyal D, Negi V, Pal S, Adekhandi S, Sharma M, et al. Microbiology of chronic suppurative otitis media in a tertiary care setup of Uttarakhand state, India. N Am J Med Sci. 2013;5(4):282-287.

6.Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296(2):202-211.

7.Tolibov FF. Immune system: anatomy of the lymphatic system and mechanisms of immune response. Zhurnal akademicheskikh issledovaniy novogo Uzbekistana. 2024;1(2):55–58. doi:10.5281/zenodo.10688710.

8.Tolibov FF. Clinical and morphological correlations of liver cirrhosis. Eur J Mod Med Pract. 2024;4(11):515–520.

9.Tolibov FF. Extra-articular manifestations of rheumatoid arthritis. Modern Science and Research. 2025;4(5):1080–1087.

10.Tolibov FF. Impact of corticosteroid and immunosuppressive therapy on the course of chronic hepatitis: risks and prospects. Modern Science and Research. 2025;4(2):1123–1132.

11.Tolibov FF. Mononuclear cell infiltration accompanied by the progression of fibrotic and cirrhotic transformations in the liver tissue. Modern Science and Research. 2025;4(4):926–936. doi:10.5281/zenodo.15227499.

12.Tolibov FF. Pathomorphological abnormalities of the liver in patients infected with the hepatitis B virus. Modern Science and Research. 2025;4(3):1084–1093.

13.Tolibov FF. Violation of platelet aggregation and imbalance of hemostasis in patients with chronic viral hepatitis C. New Day in Medicine. 2024;6(68):264–268. Available from: https://newdayworldmedicine.com/en/article/3758

14.Tolibov FF. The syndrome of external secretory function insufficiency is a common complication of chronic pancreatitis. American Journal of Bioscience and Clinical Integrity. 2024;1(10):90–95.

15.Tolibov FF, Shuhrat o'g'li RK. Diabetik nevropatiya va uning zamonaviy terapiyasi. Journal of Innovations in Scientific and Educational Research. 2025;8(1):195–202.

Published

2026-10-20